Stephen Maxted Ansell, MD, PhD

  • 20573 Citations
  • 76 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1983 2019

Filter
Review article
2019

Immunotherapy in Hodgkin Lymphoma: The Road Ahead

Ansell, S. M., May 1 2019, In : Trends in Immunology. 40, 5, p. 380-386 7 p.

Research output: Contribution to journalReview article

Hodgkin Disease
Immunotherapy
Biomarkers
Clinical Trials
T-Lymphocytes
2018
3 Citations (Scopus)

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Wang, Y., Nowakowski, G. S., Wang, M. L. & Ansell, S. M., Apr 23 2018, In : Journal of Hematology and Oncology. 11, 1, 57.

Research output: Contribution to journalReview article

Hodgkin Disease
Programmed Cell Death 1 Receptor
Antibodies
Secondary Prevention
Radiotherapy

Immunotherapy of Hodgkin Lymphoma: Mobilizing the Patient's Immune Response

Ansell, S. M., Sep 1 2018, In : Cancer Journal (United States). 24, 5, p. 249-253 5 p.

Research output: Contribution to journalReview article

Hodgkin Disease
Immunotherapy
Reed-Sternberg Cells
Tumor Microenvironment
Stromal Cells
9 Citations (Scopus)

T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines

Horwitz, S. M., Ansell, S. M., Ai, W. Z., Barnes, J., Barta, S. K., Choi, M., Clemens, M. W., Dogan, A., Greer, J. P., Halwani, A., Bradley, M. H., Hoppe, R. T., Jacobsen, E., Jagadeesh, D., Kim, Y. H., Lunning, M. A., Mehta, A., Mehta-Shah, N., Oki, Y., Olsen, E. A. & 11 others, Pro, B., Rajguru, S. A., Shanbhag, S., Shustov, A., Sokol, L., Torka, P., Wilcox, R., William, B., Zain, J., Dwyer, M. A. & Sundar, H., Feb 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 2, p. 123-135 13 p.

Research output: Contribution to journalReview article

T-Cell Lymphoma
Natural Killer T-Cells
Guidelines
Extranodal NK-T-Cell Lymphoma
Nose
2017

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance

Paludo, J. & Ansell, S. M., Jan 1 2017, In : F1000Research. 6, 2142.

Research output: Contribution to journalReview article

Monoclonal Gammopathy of Undetermined Significance
Immunoglobulin M
Waldenstrom Macroglobulinemia
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
34 Citations (Scopus)

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

Gopal, A. K., Kahl, B. S., Flowers, C. R., Martin, P., Ansell, S. M., Abella-Dominicis, E., Koh, B., Ye, W., Barr, P. M., Salles, G. A. & Friedberg, J. W., Jun 1 2017, In : Blood. 129, 22, p. 3037-3039 3 p.

Research output: Contribution to journalReview article

10 Citations (Scopus)

Recommendations for clinical trial development in follicular lymphoma

Maddocks, K., Barr, P. M., Cheson, B. D., Little, R. F., Baizer, L., Kahl, B. S., Leonard, J. P., Fowler, N., Gordon, L. I., Link, B. K., Friedberg, J. W. & Ansell, S. M., 2017, In : Journal of the National Cancer Institute. 109, 3, djw255.

Research output: Contribution to journalReview article

Follicular Lymphoma
Clinical Trials
Therapeutics
Non-Hodgkin's Lymphoma
Biomarkers
2016
2 Citations (Scopus)

Bone marrow microenvironment in Waldenstrom's Macroglobulinemia

Jalali, S. & Ansell, S. M., Jun 1 2016, In : Best Practice and Research: Clinical Haematology. 29, 2, p. 148-155 8 p.

Research output: Contribution to journalReview article

Waldenstrom Macroglobulinemia
Bone
Bone Marrow
Cell growth
Cell proliferation
9 Citations (Scopus)

Immune checkpoint blockade in lymphoid malignancies

Thanarajasingam, G., Thanarajasingam, U. & Ansell, S. M., Jun 1 2016, In : The FEBS journal. 283, 12, p. 2233-2244 12 p.

Research output: Contribution to journalReview article

Tumors
Neoplasms
Immune system
Refractory materials
Hematologic Neoplasms
20 Citations (Scopus)

Novel agents in the treatment of Hodgkin lymphoma: Biological basis and clinical results

Younes, A. & Ansell, S. M., Jul 1 2016, In : Seminars in Hematology. 53, 3, p. 186-189 4 p.

Research output: Contribution to journalReview article

Hodgkin Disease
Reed-Sternberg Cells
Tumor Microenvironment
Therapeutics
Lymphoproliferative Disorders

Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia

Kyle, R. A., Ansell, S. M. & Kapoor, P., Jun 1 2016, In : Best Practice and Research: Clinical Haematology. 29, 2, p. 179-186 8 p.

Research output: Contribution to journalReview article

Waldenstrom Macroglobulinemia
Immunoglobulin M
Anemia
Bone
Bone Marrow
3 Citations (Scopus)

Recent advances in the management of Hodgkin lymphoma

Villasboas Bisneto, J. J. C. . & Ansell, S. M., 2016, In : F1000Research. 5, 768.

Research output: Contribution to journalReview article

Hodgkin Disease
Pharmaceutical Preparations
Chemotherapy
Immune system
Radiotherapy
71 Citations (Scopus)

Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

Leblond, V., Kastritis, E., Advani, R., Ansell, S. M., Buske, C., Castillo, J. J., García-Sanz, R., Gertz, M., Kimby, E., Kyriakou, C., Merlini, G., Minnema, M. C., Morel, P., Morra, E., Rummel, M., Wechalekar, A., Patterson, C. J., Treon, S. P. & Dimopoulos, M. A., Sep 8 2016, In : Blood. 128, 10, p. 1321-1328 8 p.

Research output: Contribution to journalReview article

Waldenstrom Macroglobulinemia
Proteasome Inhibitors
Cells
Education
Dexamethasone